Group Psychoeducational Program for Mothers of Children With High Functional Pervasive Developmental Disorders

NCT ID: NCT01243905

Last Updated: 2011-01-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2/PHASE3

Total Enrollment

74 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-09-30

Study Completion Date

2012-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine the effectiveness of group psychoeducation for the psychological distress of mothers with the children of high-functioning pervasive developmental disorder and for their behavior based on disorder traits.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pervasive Developmental Disorder (PDD) is defined by its unique symptoms such as qualitative impairment in social interaction and communication and restricted repetitive and stereotyped patterns of behavior and interests. Recently, studies have been conducted on PDD without mental retardation, and have reported that the morbidity of PDD is 0.6%-1.7%. Several studies have focused on distress of the mothers of PDD facing atypical development of their children. Some of them have indicated the associations between depression and family history of PDD. Therefore it is important to pay attention to parental mental health.

In Western countries, researchers have investigated the effectiveness of various psychotherapeutic techniques such as childcare counseling and education for mothers about how to treat their children with PDD. It has been reported that one of them which innovates pragmatical methods to manage their children and parental educational programs made improvement in parental adaptation to their children and parental mental health.

However, to the best of our knowledge, few studies have shown the effectiveness of family intervention about PDD in Japan, despite widely implementation of family psychoeducation with various approaches in medical center, public health department. New research may be needed to establish rigorous evidence base for improvement of parental mental health and of behaviors of their children with PDD.

The investigators hypothesized that psychoeducation programs for mothers in addition to treatment as usual to their children would be more effective for parental mental health and behaviors of their children with PDD than treatment usual to their children alone.

The purpose of this study is to examine the effectiveness of psychoeducation to the psychological distress of mothers with the children of high-functioning PDD and to behaviors of the children affected by disorder traits, in a randomized controlled trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pervasive Developmental Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Family psychoeducation plus TAU

Family psychoeducational therapy in addition to treatment as usual for the child (TAU)

Group Type ACTIVE_COMPARATOR

Family psychoeducational therapy plus TAU

Intervention Type OTHER

Group psychoeducation every two weeks for eight weeks in addition to treatment as usual administered by physicians

Treatment as usual

Treatment as usual for the child (TAU)

Group Type PLACEBO_COMPARATOR

Treatment as usual

Intervention Type OTHER

Treatment as usual administered by physicians

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Family psychoeducational therapy plus TAU

Group psychoeducation every two weeks for eight weeks in addition to treatment as usual administered by physicians

Intervention Type OTHER

Treatment as usual

Treatment as usual administered by physicians

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Mothers whose children have been diagnosed with any disorders by DSM-Ⅳ-TR as: 1) Autistic disorder and not mental retardation; 2) Asperger disorder; or 3) Pervasive developmental disorder not otherwise specified and not mental retardation
2. Children were diagnosed at more than 3 months before allocation
3. Children were between 2 and 6.5 years and have more than 6 months as pre-school period at allocation
4. Mothers who are native speakers of Japanese.
5. Mothers who are biological mother of and actually bringing their children.

Exclusion Criteria

1. Mothers who are at risk of taking an emotional toll and unable to understand the contents of psychoeducation for any reason.
2. Mothers who are not allowed to participate in this study judged by the doctors of the children for any reason.
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nagoya City University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nagoya City University Graduate School of Medical Sciences

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Masako Suzuki, MD

Role: PRINCIPAL_INVESTIGATOR

Nagoya City University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nagoya City University Hospital

Nagoya, Aichi-ken, Japan

Site Status RECRUITING

Nagoya City University Hospital

Nagoya, Aichi-ken, Japan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Japan

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Atsurou Yamada, MD, PhD

Role: primary

+52-851-5511 ext. 3970

Masako Suzuki, Medical Bachelor

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCUPsychiatry003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.